CIK 0001385818 · Non-accelerated filer<br>Smaller reporting company
AYTU BIOPHARMA, INC
Sign in to watch- Ticker
- AYTU
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Jun 30
- Incorporated
- DE
- Entity type
- operating
- EIN
- 470883144
- Phone
- (720) 437-6580
- Business address
- 7900 E. UNION AVENUE, SUITE 920, DENVER, CO, 80237
- Former names
- AYTU BIOSCIENCE, INC, Rosewind CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-03-16 | Disbrow Jarrett Chief Operating Officer | Grant or award · Employee Stock Option Grant | +50,000 | 50,000 | ||
| 2017-03-16 | Disbrow Jarrett Chief Operating Officer | Grant or award · Employee Stock Option Grant | +60,000 | 60,000 | ||
| 2017-03-16 | Disbrow Joshua R. Chief Executive Officer | Returned to the company · Employee Stock Option Grant | −50,000 | 0 | ||
| 2017-03-16 | Disbrow Joshua R. Chief Executive Officer | Returned to the company · Employee Stock Option Grant | −60,000 | 0 | ||
| 2017-03-16 | Disbrow Joshua R. Chief Executive Officer | Grant or award · Employee Stock Option Grant | +50,000 | 50,000 | ||
| 2017-03-16 | Disbrow Joshua R. Chief Executive Officer | Grant or award · Employee Stock Option Grant | +60,000 | 60,000 | ||
| 2017-02-27 | Cantrell Gary Director | Option exercise | +37,083 | $0.75 | $28K | 135,416 |
| 2017-02-27 | Cantrell Gary Director | Option exercise · Warrant to Purchase Common Stock | −33,333 | 0 | ||
| 2017-02-27 | Cantrell Gary Director | Option exercise · Warrant to Purchase Common STock | −3,750 | 0 | ||
| 2017-02-27 | Gould Gregory A Chief Financial Officer | Option exercise | +66,666 | $0.75 | $50K | 340,231 |
| 2017-02-27 | Gould Gregory A Chief Financial Officer | Option exercise · Warrant to Purchase Common Stock | −66,666 | 0 | ||
| 2017-02-27 | DOCKERY CARL Director | Option exercise | +416,667 | $0.75 | $313K | 837,300 |
| 2017-02-27 | DOCKERY CARL Director | Option exercise · Warrant to Purchase Common Stock | −416,667 | 0 | ||
| 2017-02-27 | Cantrell Gary Director | Option exercise | +37,083 | $0.75 | $28K | 135,416 |
| 2017-02-27 | Cantrell Gary Director | Option exercise · Warrant to Purchase Common Stock | +33,333 | 0 | ||
| 2017-02-27 | Cantrell Gary Director | Option exercise · Warrant to Purchase Common STock | +3,750 | 0 | ||
| 2017-02-27 | Disbrow Jarrett Chief Operating Officer | Option exercise | +187,500 | $0.75 | $141K | 601,004 |
| 2017-02-27 | Disbrow Jarrett Chief Operating Officer | Option exercise · Warrant to Purchase Common Stock | −166,666 | 0 | ||
| 2017-02-27 | Disbrow Jarrett Chief Operating Officer | Option exercise · Warrant to Purchase Common Stock | −20,834 | 0 | ||
| 2017-02-27 | Disbrow Joshua R. Chief Executive Officer | Option exercise | +187,500 | $0.75 | $141K | 630,194 |
Page 12 of 15 · 300 trades